VOGELXO
Total Payments
$339,052
Transactions
39
Doctors
0
Companies
1
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2024 | $51,598 | 2 | 0 |
| 2023 | $287,454 | 37 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $339,052 | 39 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| VOGELXO(R) ABPM STUDY IN HYPOGANDAL MEN | UPSHER-SMITH LABORATORIES LLC | $287,454 | 0 |
| P361-502 | UPSHER-SMITH LABORATORIES LLC | $51,598 | 0 |
Top Doctors Receiving Payments for VOGELXO
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | San Antonio, TX | $339,052 | 39 |
Ad
Manufacturing Companies
- UPSHER-SMITH LABORATORIES LLC $339,052
Product Information
- Type Drug
- Total Payments $339,052
- Total Doctors 0
- Transactions 39
About VOGELXO
VOGELXO is a drug associated with $339,052 in payments to 0 healthcare providers, recorded across 39 transactions in the CMS Open Payments database. The primary manufacturer is UPSHER-SMITH LABORATORIES LLC.
Payment data is available from 2023 to 2024. In 2024, $51,598 was paid across 2 transactions to 0 doctors.
The most common payment nature for VOGELXO is "Unspecified" ($339,052, 100.0% of total).
VOGELXO is associated with 2 research studies, including "VOGELXO(R) ABPM STUDY IN HYPOGANDAL MEN" ($287,454).